AHE announces their new ENGAGE Platform with Clorox Healthcare
ENGAGE: Robust Education Platform for Professionals Caring for Healthcare Environments Yearlong series designed to enhance knowledge
March 1, 2013 -- PRESS RELEASE
Chicago, March 1, 2013 - The Association for the Healthcare Environmental (AHE) of the American Hospital Association announces their new ENGAGE Platform with Clorox Healthcare, a longstanding AHE partner committed to advancing the professional development of Environmental Services professionals.
AHE members can take advantage of free education programs from the Association for the Healthcare Environment. After listening to the membership, the AHE board made a unanimous decision at last year’s annual conference to offer free education to members as part of their dues with a modest increase. Thanks to the generous support from Clorox Healthcare, AHE members can take advantage of seven (7) online courses, including two new courses, “Ultimate Scores for the Ultimate Experience: How Improving Patient Satisfaction Will Improve HCAHPS” and “Lean Management System” and nine (9) on demand webcasts from well-known environmental services leaders.
Information on how to access these educational opportunities is posted on the AHE website at www.ahe.org. Members must register or sign in to the website and add their membership number before accessing this information. Become a member today to take advantage of this limited opportunity.
AHE and Clorox Healthcare are making this offer available beginning January 1, 2013 and ending on December 31, 2013.
-
Most popular related searches
Related news
-
SeqOne Genomics closes €20M series A to accelerate the deployment of its genomic medicine platform
The round, led by Omnes, Merieux Equity Partners, together with the Software Club and existing investors, Elaia and IRDI Capital Investissement, will enable SeqOne Genomics to accelerate its international sales and the development of new collaborative genomic analysis tools to facilitate communications between different disciplines in the medical team, in order to improve patient outcomes in cancer and hereditary disease. The company will intensify investments in the development of its genomic-aware data lake to...
-
Daxor Corporation to Commence Trading on the Nasdaq Capital Market
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that it will commence trading on The Nasdaq Capital Market effective at the opening of trading on February 2, 2022, transferring the listing of its common stock from the New York Stock Exchange – American. Daxor’s common stock will continue trading under the ticker symbol “DXR” after the transfer. The Company’s common stock will continue to trade on the NYSE American until the...
-
The Indoor Microbiome and Its Impact on Indoor Environmental Quality
Last year, the U.S. Environmental Protection Agency (EPA) announced the release of a new webpage to provide information about the indoor microbiome. All of the living microorganisms inside of an indoor environment, and their by-products, are collectively known as the indoor microbiome. The indoor microbiome that surrounds each of us is diverse and dynamic, made up of bacteria, viruses, fungi and other single-celled organisms. These microorganisms may be growing or inactive, and may be present in different life...
-
Daxor Corporation to Present at the H.C. Wainwright BioConnect 2022 Virtual Conference
Daxor Corporation (NYSE: DXR), the global leader in blood volume measurement technology, today announces that CEO and President Michael Feldschuh will present a corporate overview at the H.C. Wainwright BioConnect 2022 Virtual Conference, which is taking place on January 10 – 13, 2022. Mr. Feldshuh will provide company updates and key highlights, including a new patent award and progress with BVA-100® next generation development. The presentation will be available on-demand beginning at 7:00 a.m. ET...
-
Daxor Announces Key Milestones Achieved for Multicenter BVA-100 Study in Hospitalized Patients With COVID-19
Daxor Corporation (NYSE MKT: DXR), the global leader in blood volume measurement technology, today announces patient enrollment is complete and data analysis is underway in preparation for publication of the multi-center observational prospective study utilizing Daxor’s BVA-100 (Blood Volume Analyzer, “BVA”) technology in hospitalized COVID-19 patients. NYU Langone Health, Wake Forest School of Medicine and OHSU have been enrolling subjects since the onset of the pandemic. Dr. Jan Bakker, MD,...
Customer comments
No comments were found for AHE announces their new ENGAGE Platform with Clorox Healthcare. Be the first to comment!